NOVEL IMMUNOMODULATOR A-007 OF HUMAN PAPPILOMAVIRUS INFECTION: A PHASE II STUDY

人乳头瘤病毒感染的新型免疫调节剂 A-007：II 期研究

• 批准号: 7606954
• 负责人: BRUCE J DEZUBE
• 金额: $ 0.12万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606954
• 关键词: A-007; Anus; Area; Computer Retrieval of Information on Scientific Projects Database; Funding; Gel; Grant; Human; Immunomodulators; Infection; Institution; Monitor; Phase; Protocols documentation; Purpose; Research; Research Personnel; Resources; Source; Squamous intraepithelial lesion; Topical application; Toxic effect; United States National Institutes of Health; novel; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this protocol is to determine the acceptability and toxicity of A-007 0.25% gel applied to the anal/perianal area, as part of the treatment of high-grade squamous intraepithelial lesions. Also to monitor any local responses from topically applied A-007 as the treatment for high grade squamous intraepithelial lesions.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本方案的目的是确定 A-007 0.25% 凝胶应用于肛门/肛周区域的可接受性和毒性，作为治疗高级鳞状上皮内病变的一部分。 还监测局部应用 A-007 作为治疗高级鳞状上皮内病变的任何局部反应。